Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effects of Lung Recruitment on Cerebral Hemodynamics(LRCH)

18. November 2026 aktualisiert von: Xingui Dai, First People's Hospital of Chenzhou

Effects of Lung Recruitment on Cerebral Hemodynamics: a Single-center, Prospective, Randomized-order, Three-period, Self-controlled Design Trial

Patients receiving invasive mechanical ventilation may develop alveolar derecruitment due to atelectasis, secretion retention, changes in body position, or acute respiratory distress syndrome. Lung recruitment maneuvers reopen partially collapsed alveoli by briefly increasing transpulmonary pressure, thereby improving lung volume and oxygenation; however, elevated airway pressure may also affect venous return, mean arterial pressure, and carbon dioxide elimination, and thus alter cerebral blood flow. Therefore, improved oxygenation does not necessarily indicate stable cerebral circulation.

At present, when selecting a lung recruitment modality in clinical practice, clinicians often rely on oxygenation response, respiratory mechanics, and operator experience, while dynamic observation of cerebral hemodynamics remains relatively insufficient. Recording only two time points before and after the maneuver may miss transient but clinically meaningful changes during pressurization, maintenance of high pressure, and recovery. Therefore, under controlled and safe conditions, it is necessary to use three commonly used clinical lung recruitment maneuvers as observational scenarios to describe cerebral hemodynamic changes during lung recruitment and to explore possible physiological factors in conjunction with cardiac output, systemic blood pressure, carbon dioxide, and respiratory mechanics. The findings are expected to provide a physiological basis for bedside cerebral perfusion monitoring and risk identification; however, short-term changes in Vm alone cannot prove that a particular maneuver is safer or improves long-term outcomes.

Studienübersicht

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • (1)Age 18 years or older.
  • (2)Receiving invasive mechanical ventilation through an endotracheal tube or tracheostomy.
  • (3)A clinical indication for a lung recruitment maneuver, with an expectation that three bedside observation periods can be completed during hospitalization.
  • (4)An adequate temporal acoustic window for reproducible transcranial Doppler recordings and an adequate echocardiographic window for reproducible left ventricular outflow tract velocity-time integral measurements.
  • (5)Axillary temperature between 36.0°C and 37.3°C.
  • (6)Written informed consent provided by the participant or a legally authorized representative.

Exclusion Criteria:

  • (1)Current use of vasoactive medications.
  • (2)Known severe cardiac dysfunction or severe pulmonary hypertension.
  • (3)Undrained pneumothorax, marked airflow limitation, giant pulmonary bullae, or another condition associated with a high risk of barotrauma.
  • (4)Known markedly elevated intracranial pressure or escalating treatment for intracranial hypertension.
  • (5)Any other condition that, in the investigator's judgment, makes participation inappropriate.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Sequence 1: A-B-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Experimental: Sequence 2: B-C-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Experimental: Sequence 3: C-A-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Experimental: Sequence 1: A-C-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Experimental: Sequence 1: B-A-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Experimental: Sequence 1: C-B-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
mean flow velocity in the middle cerebral artery
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Middle cerebral artery mean flow velocity (Vm, cm/s) will be measured using transcranial Doppler ultrasonography (TCD). In each study period, measurements will be obtained after at least 10 minutes of stable baseline ventilation. For method A, measurements will be obtained during the final 10 seconds of each 60-second PEEP step and 60 seconds after return to the original ventilation settings. For method B, measurements will be obtained at 35-40 seconds of sustained inflation and 40 seconds after return to the original settings. For method C, measurements will be obtained at baseline and 60 seconds after return to the original settings following the 120-second maneuver. No intra-maneuver TCD measurement is scheduled for method C.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Systolic blood flow velocity (Vs) of the middle cerebral artery
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The Systolic blood flow velocity (Vs) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
diastolic blood flow velocity (Vd) of the middle cerebral artery
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The diastolic blood flow velocity (Vd) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
pulsatility index (PI) of the middle cerebral artery
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The pulsatility index (PI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
resistance index(RI) of the middle cerebral artery
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The resistance index(RI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
Arterial partial pressure of carbon dioxide (PaCO2)
Zeitfenster: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaCO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial partial pressure of oxygen (PaO2)
Zeitfenster: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood pH
Zeitfenster: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood pH will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood lactate concentration
Zeitfenster: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood lactate concentration (mmol/L) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Left ventricular outflow tract velocity-time integral (LVOT-VTI)
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

LVOT-VTI (cm) will be measured by Doppler echocardiography at the same prespecified time points as transcranial Doppler measurements in each study period. The measured value and its change from the period-specific pre-maneuver baseline will be reported. For method C, measurements are scheduled only at baseline and during recovery, not during the 120-second maneuver.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
End-tidal carbon dioxide (EtCO2)
Zeitfenster: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

EtCO2 (mmHg) will be monitored by capnography. A valid end-expiratory value will be recorded at the same prespecified time points as the TCD and LVOT-VTI measurements in each study period. The measured value and change from the period-specific baseline will be reported. If no valid expiratory waveform is available at a time point, the value will be recorded as missing.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienstuhl: Xingui Dai PhD, PHD, Chen Zhou NO.1 People's Hospital

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. November 2026

Primärer Abschluss (Geschätzt)

1. April 2028

Studienabschluss (Geschätzt)

1. Mai 2028

Studienanmeldedaten

Zuerst eingereicht

6. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

18. November 2026

Zuerst gepostet (Tatsächlich)

20. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

20. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

18. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

IPD-Sharing-Zeitrahmen

Beginning 6 months after publication of the main study results and available for 3 years.

IPD-Sharing-Zugriffskriterien

Qualified researchers may submit a written request including research purpose, analysis plan, requested data elements, and data protection measures. Requests will be reviewed by the principal investigator and the institution.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren